Report Categories
View AllRecent Articles
View All
AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks
TBMC Trailblazer highlights robust crossindustry merger pipeline as core priority in new quarterly earnings report
XPLR XIFR Stock Annual Dividend Trend Strengthens 20260427
Should I buy or sell NIP Group NIPG stock today Q2 2025 EPS Misses Views
PKST Peakstone posts Q4 2025 profit versus expected loss shares tick modestly higher after results